Tetrahydroaminoacridine en es it fr

Tetrahydroaminoacridine Brand names, Tetrahydroaminoacridine Analogs

Tetrahydroaminoacridine Brand Names Mixture

  • No information avaliable

Tetrahydroaminoacridine Chemical_Formula


Tetrahydroaminoacridine RX_link


Tetrahydroaminoacridine fda sheet

Tetrahydroaminoacridine msds (material safety sheet)

Tetrahydroaminoacridine MSDS

Tetrahydroaminoacridine Synthesis Reference

No information avaliable

Tetrahydroaminoacridine Molecular Weight

198.264 g/mol

Tetrahydroaminoacridine Melting Point

183.5 oC

Tetrahydroaminoacridine H2O Solubility

217 mg/L

Tetrahydroaminoacridine State


Tetrahydroaminoacridine LogP


Tetrahydroaminoacridine Dosage Forms

No information avaliable

Tetrahydroaminoacridine Indication

For the treatment of mild to moderate dementia of the Alzheimer's type.

Tetrahydroaminoacridine Pharmacology

Tacrine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Tacrine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, tacrine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that tacrine alters the course of the underlying dementing process.

Tetrahydroaminoacridine Absorption

Tacrine is rapidly absorbed. Absolute bioavailability of tacrine is approximately 17 ± 13%.

Tetrahydroaminoacridine side effects and Toxicity

No information avaliable

Tetrahydroaminoacridine Patient Information

No information avaliable

Tetrahydroaminoacridine Organisms Affected

Humans and other mammals